On September 24, Gelonhui reported that Hongyuan Pharmaceutical (301246.SZ) recently received a notice from Supervisors Mr. Duan Xiaoliu and Mr. Lei Gaoliang regarding the expiration of the shareholding reduction plan and the results of the reduction. As of September 23, 2024, the term of the shareholding reduction plan by the two individuals has expired, with a total reduction of 1.1 million shares.
宏源药业(301246.SZ)：监事段小六、雷高良减持期届满 已减持合计110万股
Hongyuan Pharmaceutical (301246.SZ): Supervisor Duan Xiaoliu and Lei Gaoliang's shareholding period has expired, already reduced a total of 1.1 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated